Connor Griffin
Role not yet determined Is this you? Add your title
Also affiliated: University of South Carolina (2023); Baylor University Medical Center (2017–2023)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Connor Griffin's research focuses on health disparities and outcomes within specific patient populations, particularly concerning liver disease and hepatocellular carcinoma. He has investigated trends in cirrhosis-related mortality among Medicare beneficiaries, analyzing data from 1999 to 2018. Griffin also examines hepatocellular carcinoma-related mortality in the United States over the same period. His work includes assessing estimated glomerular filtration rates in patients with cirrhosis and contributing to patient-friendly summaries of clinical guidelines for conditions like nonalcoholic fatty liver disease. Griffin's scholarship metrics include an h-index of 7, with 17 total publications and 193 citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Ruud P.M. Dings, Eric R. Siegel, R. Eric Davis, and Gunnar Boysen.
Metrics
- h-index: 7
- Publications: 16
- Citations: 190
Selected Publications
-
CB-839 induces reversible dormancy in lung tumor-cells (2024)
-
Virtual Reality in the Neurosciences: Current Practice and Future Directions (2022)
Collaboration Network
Top Collaborators
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
Similar Researchers
Based on overlapping research topics